58652-20-3

58652-20-3 structure

Name: Nomegestrol acetate
Chemical Name: Nomegestrol acetate
CAS Number: 58652-20-3
Molecular Formula: C₂₃H₃₀O₄
Molecular Weight: 370.482
Catalog: API Hormone and endocrine-regulating drugs Estrogen and progestogen drugs
Create Date: 2018-03-25 08:00:00
Modify Date: 2024-01-10 13:00:43
Nomegestrol acetate is a potent, highly selective progestogen, which is characterized as a full agonist at the progesterone receptor, with no or minimal binding to other steroid receptors, including the androgen and glucocorticoid receptors[1].

Name	Nomegestrol acetate
Synonyms	[(8S,9S,10R,13S,14S,17R)-17-acetyl-6,13-dimethyl-3-oxo-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate EINECS 261-379-8 6-Methyl-3,20-dioxo-19-norpregna-4,6-dien-17-yl acetate Lutenyl (17a)-17-Acetyl-6-methyl-3-oxoestra-4,6-dien-17-yl acetate MFCD00941390 17-Acetoxy-6-methyl-19-norpregna-4,6-diene-3,20-dione Nomegestrol acetate Estra-4,6-dien-3-one, 17-acetyl-17-(acetyloxy)-6-methyl-, (17α)- 19-normegestrol acetate

Description	Nomegestrol acetate is a potent, highly selective progestogen, which is characterized as a full agonist at the progesterone receptor, with no or minimal binding to other steroid receptors, including the androgen and glucocorticoid receptors[1].
Related Catalog	Signaling Pathways >> Others >> Progesterone Receptor Research Areas >> Endocrinology
Target	Progesterone receptor[1]
References	[1]. Mueck AO, et al. Nomegestrol acetate, a novel progestogen for oral contraception. Steroids. 2011 May;76(6):531-9.

Density	1.2±0.1 g/cm3
Boiling Point	507.3±50.0 °C at 760 mmHg
Molecular Formula	C₂₃H₃₀O₄
Molecular Weight	370.482
Flash Point	219.8±30.2 °C
Exact Mass	370.214417
PSA	60.44000
LogP	3.34
Vapour Pressure	0.0±1.3 mmHg at 25°C
Index of Refraction	1.554
Storage condition	2-8°C

CHEMICAL IDENTIFICATION

RTECS NUMBER :: RC8899200

CHEMICAL NAME :: 19-Norpregna-4,6-diene-3,20-dione, 17-alpha-hydroxy-6-methyl-, acetate

CAS REGISTRY NUMBER :: 58652-20-3

LAST UPDATED :: 199603

DATA ITEMS CITED :: 6

MOLECULAR FORMULA :: C23-H30-O4

MOLECULAR WEIGHT :: 370.53

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Human - woman

DOSE/DURATION :: 1050 ug/kg/21D-I

TOXIC EFFECTS :: Endocrine - changes in luteinizing hormone Endocrine - estrogenic Endocrine - effect on menstrual cycle

REFERENCE :: BJOGAS British Journal of Obstetrics and Gynaecology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.82- 1975- Volume(issue)/page/year: 94,1199,1987

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: >2 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 9,657,1984

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: >2 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 9,657,1984

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: >2 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 9,657,1984

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: >2 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 9,657,1984 ** REPRODUCTIVE DATA **

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

DOSE :: 5 mg/kg

SEX/DURATION :: female 4 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Fertility - other measures of fertility

REFERENCE :: ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 33,710,1983

Symbol	GHS08, GHS09
Signal Word	Warning
Hazard Statements	H361fd-H400
Precautionary Statements	P280
Hazard Codes	N
Risk Phrases	63-50
Safety Phrases	61
RIDADR	UN 3077 9 / PGIII
RTECS	RC8899200

58652-20-3	853244-42-5
58691-88-6	6426-44-4
29066-34-0	54324-99-1
10483-91-7	6046-93-1
27569-23-9	58735-82-3